Characterisation of atovaquone resistance in Leishmania infantum promastigotes

International Journal for Parasitology

Volumn 32, Issue 8, 2002, Pages 1043-1051

  Cauchetier, E ^a,f   Loiseau, P M ^b   Lehman, J ^c   Rivollet, D ^d   Fleury, J ^c   Astier, A ^a,e   Deniau, M ^d   Paul, M ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c HÔPITAL TENON   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e UNIVERSITÉ DE LORRAINE   (France)

^f CENTRE HOSPITALIER VICTOR DUPOUY   (France)

Author keywords

Atovaquone; Cellular alterations; Leishmania infantum promastigotes; Membrane lipidic composition; Multi drug resistance phenotype; Resistance

Indexed keywords

AMPHOTERICIN B; ATOVAQUONE; CHOLESTEROL; DIMETHYL SULFOXIDE; ERGOSTEROL; GLYCOPROTEIN P; KETOCONAZOLE; PAROMOMYCIN; PENTAMIDINE ISETHIONATE; RHODAMINE; STEROL;

DRUG RESISTANCE; LEISHMANIASIS;

ANTIBIOTIC RESISTANCE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS RESISTANCE; CULTURE MEDIUM; DRUG PENETRATION; LEISHMANIA INFANTUM; LIPID COMPOSITION; MEMBRANE FLUIDITY; NONHUMAN; PHENOTYPE; PROMASTIGOTE; PROTEIN EXPRESSION; STEROL SYNTHESIS; STRAIN DIFFERENCE; STRAIN IDENTIFICATION;

ANIMALS; ANTIPROTOZOAL AGENTS; ATOVAQUONE; BIOLOGICAL TRANSPORT; CELL MEMBRANE; CHOLESTEROL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; FATTY ACIDS; LEISHMANIA INFANTUM; LEISHMANIASIS; NAPHTHOQUINONES; P-GLYCOPROTEIN; RHODAMINES; TIME FACTORS;

LEISHMANIA INFANTUM;

EID: 0036076250     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(02)00065-6     Document Type: Article

References (39)

1. Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica
2. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes
3. Sterol structure and membrane function
4. Therapy in man
5. Effect of sterol side chains on growth and membrane fatty acid composition of Saccharomyces cerevisiae
6. Therapeutic evaluation of free and liposome-encapsulated atovaquone in the treatment of murine leishmaniasis
7. Altered drug membrane permeability in a multidrug-resistant Leishmania tropica line
8. Plasmodium and Leishmania: The role of mdr genes in mediating drug resistance
9. The activity of hydroxynaphthoquinones against Leishmania donovani
10. Function, evolution and structure of multidrug resistance protein (MRP)
11. The function of sterols in membranes
12. Co-infections of Leishmania/HIV in south Europe
13. In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 387 strains collected from patients with visceral leishmaniasis
14. Paromomycin resistance in Leishmania tropica: Lack of correlation with mutation in the small subunit ribosomal RNA gene
15. Stable amplified DNA in drug-resistant Leishmania exists as extrachromosomal circles
16. Lipid membrane structure and interactions in dimethyl sulfoxide/water mixtures
17. Leishmania spp: Development of pentostam-resistant clones in vitro by discontinuous drug exposure
18. Leishmania amazonensis: Multidrug resistance in vinblastine-resistant promastigotes is associated with rhodamine 123 efflux, DNA amplification, and RNA overexpression of Leishmania mdr1 gene
19. Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages
20. In vitro activity of atovaquone against Leishmania chagasi promastigotes
21. Effects of vinblastine, colchicines, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells
22. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen
23. Development and characterization of paromomycin-resistant Leishmania donovani promastigotes
24. Mechanism of amphotericin B resistance in Leishmania donovani promastigotes
25. o domain mutations as a mechanism of atovaquone-resistance
26. A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue
27. Leishmania donovani: Pilot study for evaluation of therapeutic effects of inosine analogs against amastigotes in vitro and in vivo
28. Treatment of visceral leishmaniasis (kala-azar): A decade of progress and future approaches
29. Activity of oral atovaquone alone or in combination with antimony experimental visceral leishmaniasis
30. Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania
31. Mechanisms of drug resistance in Leishmania
32. Experimental production of drug resistance
33. Mechanism of action of amphotericin B on Leishmania donovani promastigotes
34. Increased P-type ATPase activity in Leishmania tropica resistant to methotrexate
35. The physiological function of drug-transporting P-glycoproteins
36. A spin label study of the effects of sterols on egg lecithin bilayers
37. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites
38. Mutations in the cytochrome b gene of plasmodium berghei conferring resistance to atovaquone
39. The modulation of membrane structure and stability by dimethyl sulphoxide (review)